NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 198 filers reported holding NOVOCURE LTD in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $80,700,000 | +6.4% | 725,000 | -39.6% | 0.56% | +13.2% |
| Q2 2019 | $75,876,000 | +50.0% | 1,200,000 | +14.3% | 0.49% | +29.7% |
| Q1 2019 | $50,579,000 | +20.9% | 1,050,000 | -16.0% | 0.38% | +23.8% |
| Q4 2018 | $41,850,000 | -40.8% | 1,250,000 | -7.4% | 0.31% | -26.6% |
| Q3 2018 | $70,740,000 | +42.1% | 1,350,000 | -15.1% | 0.42% | +36.2% |
| Q2 2018 | $49,767,000 | +23.4% | 1,590,000 | -14.1% | 0.31% | +10.0% |
| Q1 2018 | $40,330,000 | +71.4% | 1,850,000 | +58.8% | 0.28% | +46.1% |
| Q4 2017 | $23,533,000 | – | 1,165,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |